Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Behav Processes ; 103: 327-33, 2014 Mar.
Article En | MEDLINE | ID: mdl-24496020

Stress has been shown to negatively affect the immune system, alter the body's metabolism, and play a strong role in the development of mood disorders. These effects are mainly driven through the release of hormones from the hypothalamic-pituitary-adrenal axis (HPA). Additionally, women are more likely to be affected by stress due to the estrogen fluctuation associated with their menstrual cycle. This study aims to evaluate the effect of chronic restraint stress, applied for 30 days, and estrogen replacement on behavior, glucose level, and the lipid profile of ovariectomized rats. Our results suggest that stress increases sweet food consumption in OVX females treated with estradiol (E2), but reduces consumption in animals not treated. Furthermore, stress increases locomotor activity and anxiety as assessed by the Open Field test and in the Elevated Plus Maze. Similarly, our results suggest that E2 increases anxiety in female rats under the same behavioral tests. In addition, stress reduces glucose and TC levels. Moreover, stress increase TG levels in the presence of E2 and decrease in its absence, as well as the estradiol increase TG levels in stressed groups and reduced in non-stressed groups. Our data suggest an important interaction between stress and estrogen, showing that hormonal status can induce changes in the animal's response to stress.


Behavior, Animal/drug effects , Estrogens/pharmacology , Glycemic Index/drug effects , Lipid Metabolism/drug effects , Ovariectomy , Stress, Psychological/metabolism , Stress, Psychological/psychology , Adrenal Glands/drug effects , Adrenal Glands/physiology , Animals , Anxiety/psychology , Eating/drug effects , Estradiol/pharmacology , Female , Hormone Replacement Therapy , Motor Activity/drug effects , Organ Size/drug effects , Rats , Restraint, Physical , Taste/drug effects , Weight Gain/drug effects , Weight Gain/physiology
2.
Cell Transplant ; 23(8): 981-94, 2014.
Article En | MEDLINE | ID: mdl-23562290

A human embryonic stem cell (HESC) line, H1, was studied after differentiation to a dopaminergic phenotype in vitro in order to carry out in vivo studies in Parkinsonian monkeys. To identify morphological characteristics of transplanted donor cells, HESCs were transfected with a GFP lentiviral vector. Gene expression studies were performed at each step of a neural rosette-based dopaminergic differentiation protocol by RT-PCR. In vitro immunofluorescence revealed that >90% of the differentiated cells exhibited a neuronal phenotype by ß-III-tubulin immunocytochemistry, with 17% of the cells coexpressing tyrosine hydroxylase prior to implantation. Biochemical analyses demonstrated dopamine release in culture in response to potassium chloride-induced membrane depolarization, suggesting that the cells synthesized and released dopamine. These characterized, HESC-derived neurons were then implanted into the striatum and midbrain of MPTP (1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine)-exposed monkeys that were triple immunosuppressed. Here we demonstrate robust survival of transplanted HESC-derived neurons after 6 weeks, as well as morphological features consistent with polarization, organization, and extension of processes that integrated into the host striatum. Expression of the dopaminergic marker tyrosine hydroxylase was not maintained in HESC-derived neural grafts in either the striatum or substantia nigra, despite a neuronal morphology and expression of ß-III-tubulin. These results suggest that dopamine neuronal cells derived from neuroectoderm in vitro will not maintain the correct midbrain phenotype in vivo in nonhuman primates, contrasted with recent studies showing dopamine neuronal survival using an alternative floorplate method.


1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/metabolism , Dopaminergic Neurons/cytology , Embryonic Stem Cells/cytology , Neurons/cytology , Parkinson Disease/therapy , Stem Cell Transplantation/methods , Animals , Cell Differentiation/physiology , Chlorocebus aethiops , Dopamine/metabolism , Dopaminergic Neurons/metabolism , Embryonic Stem Cells/metabolism , Humans , Male , Neurons/metabolism , Parkinson Disease/metabolism , Parkinson Disease/pathology
3.
Neurosci Lett ; 488(1): 11-6, 2011 Jan 13.
Article En | MEDLINE | ID: mdl-21056633

Previous studies in Parkinson's disease (PD) models suggest that early events along the path to neurodegeneration involve activation of the ubiquitin-proteasome system (UPS), endoplasmic reticulum-associated degradation (ERAD), and the unfolded protein response (UPR) pathways, in both the sporadic and familial forms of the disease, and thus ER stress may be a common feature. Furthermore, impairments in protein degradation have been linked to oxidative stress as well as pathways associated with ER stress. We hypothesize that oxidative stress is a primary initiator in a multi-factorial cascade driving dopaminergic (DA) neurons towards death in the early stages of the disease. We now report results from proteomic analysis of a rotenone-induced oxidative stress model of PD in the human neuroblastoma cell line, SH-SY5Y. Cells were exposed to sub-micromolar concentrations of rotenone for 48h prior to whole cell protein extraction and shotgun proteomic analysis. Evidence for activation of the UPR comes from our observation of up-regulated binding immunoglobulin protein (BiP), heat shock proteins, and foldases. We also observed up-regulation of proteins that contribute to the degradation of misfolded or unfolded proteins controlled by the UPS and ERAD pathways. Activation of the UPR may allow neurons to maintain protein homeostasis in the cytosol and ER despite an increase in reactive oxygen species due to oxidative stress, and activation of the UPS and ERAD may further augment clean-up and quality control in the cell.


Oxidative Stress/physiology , Proteomics , Analysis of Variance , Apoptosis/drug effects , Caspase 3/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Chaperone BiP , Enzyme-Linked Immunosorbent Assay/methods , Heat-Shock Proteins/metabolism , Humans , Insecticides/pharmacology , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Oxidative Stress/drug effects , Proteome/metabolism , Rotenone/pharmacology , Signal Transduction/drug effects , Up-Regulation/drug effects
...